跳转至内容
Merck
CN

C5041

6-羧基荧光素二乙酸酯

~95% purity (HPLC), powder

别名:

6-CFDA, 6-羧基-二--乙酰荧光素

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C25H16O9
化学文摘社编号:
分子量:
460.39
NACRES:
NA.47
PubChem Substance ID:
UNSPSC Code:
12171500
MDL number:
Beilstein/REAXYS Number:
67043
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

6-羧基荧光素二乙酸酯, ≥95% (HPLC)

Quality Level

assay

≥95% (HPLC)

form

powder

color

white to yellow

solubility

chloroform/ethanol (1:1): 9.80-10.20 mg/mL, clear, colorless to light yellow

application(s)

diagnostic assay manufacturing
hematology
histology

storage temp.

−20°C

SMILES string

CC(=O)Oc1ccc2c(Oc3cc(OC(C)=O)ccc3C24OC(=O)c5ccc(cc45)C(O)=O)c1

InChI

1S/C25H16O9/c1-12(26)31-15-4-7-18-21(10-15)33-22-11-16(32-13(2)27)5-8-19(22)25(18)20-9-14(23(28)29)3-6-17(20)24(30)34-25/h3-11H,1-2H3,(H,28,29)

InChI key

QMOGCCYGOPYYNT-UHFFFAOYSA-N

Application

6-羧基荧光素二乙酸酯已用于区分活细胞和凋亡细胞。 非凋亡的活细胞聚集 6-羧基荧光素,但不聚集膜联蛋白。
荧光波长 λex 492 nm;λem 517 nm 溶于 0.1M Tris,pH 8.0。


存储类别

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

一氧化氮 (NO) 是神经元、内皮细胞和免疫系统中的信号转运分子。

Nitric oxide (NO) as a signal transporter in neurons, endothelial cells and in the immune system.


Garry R Smith et al.
Journal of molecular neuroscience : MN, 52(3), 446-458 (2013-11-28)
Severe seizure activity is associated with reoccurring cycles of excitotoxicity and oxidative stress that result in progressive neuronal damage and death. Intervention with these pathological processes is a compelling disease-modifying strategy for the treatment of seizure disorders. We have optimized
Douglas E Brenneman et al.
Journal of molecular neuroscience : MN, 47(2), 368-379 (2012-04-27)
Severe seizure activity is associated with recurring cycles of excitotoxicity and oxidative stress that result in progressive neuronal damage and death. Intervention to halt these pathological processes is a compelling disease-modifying strategy for the treatment of seizure disorders. In the
Chander Parkash Dora et al.
International journal of pharmaceutics, 530(1-2), 113-127 (2017-07-26)
The aim of the present research is to increase lipid solubility, metabolic stability and therapeutic efficacy of water soluble gemcitabine (GEM) via phospholipid complex (PC) formation. A novel phospholipid complex of GEM was successfully prepared and optimized. Physical interaction of



全球贸易项目编号

货号GTIN
C5041-25MG04061833501702
C5041-100MG04061833501696